Patents by Inventor Yogendra Rathore

Yogendra Rathore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160324154
    Abstract: The present invention relates to ternary herbicidally active compositions, which comprise a) 5-ethyl-2-[(RS)-4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl]nicotinic acid (common name: imazethapyr) and 2-[(RS)-4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl]-5-methoxymethylnicotinic acid (common name: imazamox) and b) at least one herbicide selected from the group consisting of 5-(2-chloro-?,?,?-trifluoro-p-tolyloxy)-N-mesyl-2-nitrobenzamide (common name: fomesafen), 2?,4?-dichloro-5?-(4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl)methanesulfonanilide (common name: sulfentrazone) and 3-isopropyl-1H-2,1,3-benzothiadiazin-4(3H)-one 2,2-dioxide (common name: bentazone).
    Type: Application
    Filed: January 5, 2015
    Publication date: November 10, 2016
    Inventors: Cyrill ZAGAR, Edson BEGLIOMINI, Abhishek BEOHAR, Ajay CHANDOLA, Satish GANIGER, Sudhakar KANDRU, Yogesh OTURKAR, Yogendra RATHORE, Nilanjan SANYAL
  • Publication number: 20160324153
    Abstract: The present invention relates to herbicidally active compositions, which comprise 5-ethyl-2-[(RS)-4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl]nicotinic acid (common name: imazethapyr) and (5RS)-2-[(EZ)-1-(Ethoxyimino)butyl]-3-hydroxy-5-[(3RS)-thian-3-yl]cyclohex-2-en-1-one (common name: cycloxydim) and optionally 2-[(RS)-4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl]-5-methoxymethylnicotinic acid (common name: imazamox).
    Type: Application
    Filed: January 5, 2015
    Publication date: November 10, 2016
    Inventors: Cyrill ZAGAR, Edson BEGLIOMINI, Abhishek BEOHAR, Ajay CHANDOLA, Sudhakar KANDRU, Yogesh OTURKAR, Yogendra RATHORE, Nilanjan SANYAL, Satish GANIGER
  • Publication number: 20150071952
    Abstract: The invention provides peptides capable of binding with influenza hemagglutinin (HA) protein blocking pH-induced shape change or aggregation of the influenza hemagglutinin (HA) protein. The invention also provides a druggable site in influenza Hemagglutinin protein, said druggable site comprises peptide sequences comprising conserved residues.
    Type: Application
    Filed: February 14, 2013
    Publication date: March 12, 2015
    Inventors: Ashish Fnu, Kalpana Pandey, Yogendra Rathore